Showing results 21 to 26 of 26
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
EDP-514, a potent pangenotypic class ii hepatitis B virus core inhibitor, demonstrates significant HBV DNA and HBV RNA reductions in a phase 1b study in viremic, chronic hepatitis B infected patients Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
2012 | |||
Continued Virologic Improvement Through 96 Weeks of Entecavir Treatment in HBeAg(-) Chronic Hepatitis B Patients (Study ETV-027) Proceeding/Conference:Gastroenterology | 2006 | ||
Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(?) chronic hepatitis B patients (study ETV-027) Proceeding/Conference:Journal of Hepatology | 2006 | ||
2021 | |||
12 months lamivudine (100mg od) therapy improves liver histology: results of a placebo controlled multicentre study in Asia Proceeding/Conference:Journal of Hepatology | 1997 |